pharma · Bleeding Complication During Colon Polypectomy · Cancer of Colon
Yang Xiaotian
Yang Xiaotian is a pharma organization headquartered in CN. Primary therapeutic focus areas include Bleeding Complication During Colon Polypectomy, Cancer of Colon, Erosive Esophagitis, Gastric Cancer, Primary Aldosteron
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 5
- Drugs
- 2
- Patents
- 0
Aspirin
Unknown · small molecule · Bleeding Complication During Colon Polypectomy
Aspirin for Bleeding Complication During Colon Polypectomy is a Unknown program (small_molecule) at Yang Xiaotian with 1 ClinicalTrials.gov record(s).
Internal code KASIDPOLYP
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Yang Xiaotian
- Phase
- Unknown
- Modality
- small_molecule
- Indication
- Bleeding Complication During Colon Polypectomy
- Status
- active
- Trials
- 1